Product Classification
Classified as GLP-1/GIP dual incretin receptor agonist
Description
Mazdutide is a dual GLP-1 and GIP receptor agonist investigated for metabolic and weight management research beyond GLP-1 monotherapy effects.
Specifications
- Molecular Type: Dual incretin receptor agonist
- Mechanisms: GLP-1 + GIP signaling
Research Notes
- Weight Management: dual incretin synergy for adiposity reduction.
- Glycemic: improves insulin sensitivity and glucose tolerance in models.
- Comparison: evaluated relative to GLP■1 single agonists (e.g., semaglutide).
Regulatory StatementFor research use only. Not for human or animal consumption.
Reviews
There are no reviews yet.